These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Immunization of mice with an attenuated Salmonella typhimurium strain expressing a membrane protein of Francisella tularensis. A model for identification of bacterial determinants relevant to the host defence against tularemia. Sjöstedt A; Sandström G; Tärnvik A Res Microbiol; 1990; 141(7-8):887-91. PubMed ID: 2101478 [TBL] [Abstract][Full Text] [Related]
25. Humoral and cell-mediated immunity in mice to a 17-kilodalton lipoprotein of Francisella tularensis expressed by Salmonella typhimurium. Sjöstedt A; Sandström G; Tärnvik A Infect Immun; 1992 Jul; 60(7):2855-62. PubMed ID: 1612751 [TBL] [Abstract][Full Text] [Related]
26. Generation and characterization of hybridoma antibodies for immunotherapy of tularemia. Lu Z; Roche MI; Hui JH; Unal B; Felgner PL; Gulati S; Madico G; Sharon J Immunol Lett; 2007 Oct; 112(2):92-103. PubMed ID: 17764754 [TBL] [Abstract][Full Text] [Related]
27. A defined O-antigen polysaccharide mutant of Francisella tularensis live vaccine strain has attenuated virulence while retaining its protective capacity. Sebastian S; Dillon ST; Lynch JG; Blalock LT; Balon E; Lee KT; Comstock LE; Conlan JW; Rubin EJ; Tzianabos AO; Kasper DL Infect Immun; 2007 May; 75(5):2591-602. PubMed ID: 17296751 [TBL] [Abstract][Full Text] [Related]
28. Mouse model of oral infection with virulent type A Francisella tularensis. KuoLee R; Zhao X; Austin J; Harris G; Conlan JW; Chen W Infect Immun; 2007 Apr; 75(4):1651-60. PubMed ID: 17242058 [TBL] [Abstract][Full Text] [Related]
29. Early consequences of macrophage-Francisella tularensis interaction under the influence of different genetic background in mice. Hernychova L; Kovarova H; Macela A; Kroca M; Krocova Z; Stulik J Immunol Lett; 1997 Jun; 57(1-3):75-81. PubMed ID: 9232429 [TBL] [Abstract][Full Text] [Related]
30. Construction and characterization of an attenuated purine auxotroph in a Francisella tularensis live vaccine strain. Pechous R; Celli J; Penoske R; Hayes SF; Frank DW; Zahrt TC Infect Immun; 2006 Aug; 74(8):4452-61. PubMed ID: 16861631 [TBL] [Abstract][Full Text] [Related]
31. In vivo modulation of the murine immune response to Francisella tularensis LVS by administration of anticytokine antibodies. Leiby DA; Fortier AH; Crawford RM; Schreiber RD; Nacy CA Infect Immun; 1992 Jan; 60(1):84-9. PubMed ID: 1729199 [TBL] [Abstract][Full Text] [Related]
32. Virulence of representative Japanese Francisella tularensis and immunologic consequences of infection in mice. Hotta A; Fujita O; Uda A; Yamamoto Y; Sharma N; Tanabayashi K; Yamada A; Morikawa S Microbiol Immunol; 2016 Mar; 60(3):168-76. PubMed ID: 26853540 [TBL] [Abstract][Full Text] [Related]
33. Intranasal interleukin-12 treatment for protection against respiratory infection with the Francisella tularensis live vaccine strain. Duckett NS; Olmos S; Durrant DM; Metzger DW Infect Immun; 2005 Apr; 73(4):2306-11. PubMed ID: 15784575 [TBL] [Abstract][Full Text] [Related]
34. Early activation of NK cells after lung infection with the intracellular bacterium, Francisella tularensis LVS. López MC; Duckett NS; Baron SD; Metzger DW Cell Immunol; 2004; 232(1-2):75-85. PubMed ID: 15922718 [TBL] [Abstract][Full Text] [Related]
35. NK cells activated in vivo by bacterial DNA control the intracellular growth of Francisella tularensis LVS. Elkins KL; Colombini SM; Krieg AM; De Pascalis R Microbes Infect; 2009 Jan; 11(1):49-56. PubMed ID: 18992838 [TBL] [Abstract][Full Text] [Related]
36. Protection of vaccinated mice against pneumonic tularemia is associated with an early memory sentinel-response in the lung. Bar-On L; Cohen H; Elia U; Rotem S; Bercovich-Kinori A; Bar-Haim E; Chitlaru T; Cohen O Vaccine; 2017 Dec; 35(50):7001-7009. PubMed ID: 29102170 [TBL] [Abstract][Full Text] [Related]
37. Susceptibility of immunodeficient mice to aerosol and systemic infection with virulent strains of Francisella tularensis. Chen W; KuoLee R; Shen H; Conlan JW Microb Pathog; 2004 Jun; 36(6):311-8. PubMed ID: 15120157 [TBL] [Abstract][Full Text] [Related]
38. Transfer of specific antibodies results in increased expression of TNF-alpha and IL12 and recruitment of neutrophils to the site of a cutaneous Francisella tularensis infection. Stenmark S; Sjöstedt A J Med Microbiol; 2004 Jun; 53(Pt 6):501-504. PubMed ID: 15150328 [TBL] [Abstract][Full Text] [Related]
39. The immune response against Francisella tularensis live vaccine strain in Lps(n) and Lps(d) mice. Macela A; Stulik J; Hernychova L; Kroca M; Krocova Z; Kovarova H FEMS Immunol Med Microbiol; 1996 Mar; 13(3):235-8. PubMed ID: 8861035 [TBL] [Abstract][Full Text] [Related]
40. Prophylactic and therapeutic use of antibodies for protection against respiratory infection with Francisella tularensis. Kirimanjeswara GS; Golden JM; Bakshi CS; Metzger DW J Immunol; 2007 Jul; 179(1):532-9. PubMed ID: 17579074 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]